INNOPHARMAX, INC.
12Patents
12Active
12Granted
46Portfolio score
Filing activity: Dec 25, 2009 → Jun 2, 2017 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263578B2 | Stable bortezomib formulations | Human Necessities | 11 | Active |
| US9180093B2 | Stable bortezomib formulations | Human Necessities | 1 | Active |
| US9636376B2 | Stable compositions of peptide epoxy ketones | Human Necessities | 1 | Active |
| US9107821B2 | Stable bortezomib formulations | Human Necessities | 0 | Active |
| US8883207B2 | Controlled release carvedilol formulation | Human Necessities | 0 | Active |
| US9968614B2 | Aprepitant injectable formulations | Human Necessities | 0 | Active |
| US9750702B2 | Pharmaceutical composition for treating parkinson's disease and preparation method thereof | Human Necessities | 0 | Active |
| US8895735B2 | Preparation process of (6R)-tetrahydrobiopterin hydrochloride | Chemistry; Metallurgy | 0 | Active |
| US10835548B2 | Metronomic oral gemcitabine for cancer therapy | Human Necessities | 0 | Active |
| US11331376B2 | Oral administration of unstable or poorly-absorbed drugs | Human Necessities | 0 | Active |
| US10251891B2 | Aprepitant oral liquid formulations | Human Necessities | 0 | Active |
| US9061037B2 | Stable bortezomib formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.